Advertisement

Topics

Lexicon announces additional positive Phase III data for diabetes drug

19:00 EDT 16 Aug 2017 | Net Resources International

Lexicon Pharmaceuticals has reported additional positive data from its Phase III inTandem2 clinical trial of sotagliflozin in adult type 1 diabetes patients on a background of optimised insulin.

Original Article: Lexicon announces additional positive Phase III data for diabetes drug

NEXT ARTICLE

More From BioPortfolio on "Lexicon announces additional positive Phase III data for diabetes drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...